- Home
- TRVI vs CHMG Comparison
TRVI vs CHMG Comparison
Compare TRVI & CHMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- CHMG
- Stock Information
- Founded
- TRVI 2011
- CHMG 1833
- Country
- TRVI United States
- CHMG United States
- Employees
- TRVI N/A
- CHMG N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- CHMG Major Banks
- Sector
- TRVI Health Care
- CHMG Finance
- Exchange
- TRVI Nasdaq
- CHMG Nasdaq
- Market Cap
- TRVI 725.7M
- CHMG 224.0M
- IPO Year
- TRVI 2019
- CHMG N/A
- Fundamental
- Price
- TRVI $5.95
- CHMG $50.15
- Analyst Decision
- TRVI Strong Buy
- CHMG Hold
- Analyst Count
- TRVI 9
- CHMG 3
- Target Price
- TRVI $19.94
- CHMG $55.00
- AVG Volume (30 Days)
- TRVI 1.8M
- CHMG 13.9K
- Earning Date
- TRVI 08-07-2025
- CHMG 07-17-2025
- Dividend Yield
- TRVI N/A
- CHMG 2.54%
- EPS Growth
- TRVI N/A
- CHMG N/A
- EPS
- TRVI N/A
- CHMG 4.74
- Revenue
- TRVI N/A
- CHMG $96,163,000.00
- Revenue This Year
- TRVI N/A
- CHMG $11.98
- Revenue Next Year
- TRVI N/A
- CHMG $8.47
- P/E Ratio
- TRVI N/A
- CHMG $10.64
- Revenue Growth
- TRVI N/A
- CHMG 0.44
- 52 Week Low
- TRVI $2.36
- CHMG $40.71
- 52 Week High
- TRVI $7.48
- CHMG $55.73
- Technical
- Relative Strength Index (RSI)
- TRVI 48.10
- CHMG 63.83
- Support Level
- TRVI $5.41
- CHMG $48.37
- Resistance Level
- TRVI $6.08
- CHMG $50.05
- Average True Range (ATR)
- TRVI 0.31
- CHMG 1.83
- MACD
- TRVI -0.00
- CHMG 0.27
- Stochastic Oscillator
- TRVI 50.23
- CHMG 99.27
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About CHMG Chemung Financial Corp
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.